Friday - December 12, 2025
From Lab to Clinic: CU Anschutz Launches Phase 1 Clinical Trial of Promising Combination Therapy for Resistant Ovarian Cancer
December 04, 2025
AURORA, Colorado, Dec. 4 (TNSjou) -- The University of Colorado School of Public Health issued the following news release:

* * *

From Lab to Clinic: CU Anschutz Launches Phase 1 Clinical Trial of Promising Combination Therapy for Resistant Ovarian Cancer

First-of-its-kind combination therapy could make treatment more effective by attacking hard-to-treat cancer from two angles

By Julia Milzer

Researchers at the University of Colorad . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products